600721.SS SHH
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
1W: -9.4%
1M: -5.7%
3M: +90.0%
YTD: +40.5%
1Y: +62.2%
3Y: +80.6%
5Y: +190.0%
¥13.11 ($1.96)
+0.16 (+1.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$1.1B
-1.5% ▼
5Y CAGR: +2.4%
Total Liabilities
$294M
-17.3% ▼
5Y CAGR: -3.4%
Shareholders Equity
$802M
+5.7% ▲
5Y CAGR: +5.3%
Cash & Investments
$299M
+9.8% ▲
5Y CAGR: +40.0%
Total Debt
$2M
-42.7% ▼
Net Debt
-$296M
-9.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $87M | $136M | $202M | $272M | $299M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $87M | $136M | $202M | $272M | $299M |
| Net Receivables | $167M | $208M | $224M | $206M | $234M |
| Inventory | $194M | $149M | $125M | $100M | $30M |
| Other Current Assets | $9M | $565K | $34K | $3M | $2M |
| Total Current Assets | $468M | $506M | $565M | $583M | $565M |
| Property, Plant & Equip. | $162M | $148M | $138M | $140M | $138M |
| Goodwill & Intangibles | $23M | $23M | $32M | $47M | $52M |
| Long-Term Investments | $313M | $305M | $64M | $64M | $300M |
| Other Non-Current Assets | $2M | $4M | $248M | $248M | $7M |
| Total Non-Current Assets | $514M | $496M | $497M | $531M | $532M |
| Total Assets | $982M | $1.0B | $1.1B | $1.1B | $1.1B |
| — Liabilities — | |||||
| Accounts Payable | $58M | $93M | $101M | $87M | $57M |
| Short-Term Debt | $6M | $505K | $0 | $4M | $2M |
| Deferred Revenue | $186M | $99M | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $5M | $118M | $217M | $186M |
| Total Current Liabilities | $254M | $289M | $308M | $309M | $247M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $2M | $1M | $2M | $2M | $2M |
| Total Non-Current Liabilities | $42M | $45M | $47M | $47M | $48M |
| Total Liabilities | $296M | $334M | $355M | $356M | $294M |
| — Equity — | |||||
| Common Stock | $375M | $378M | $382M | $384M | $0 |
| Retained Earnings | -$1.9B | -$2.0B | -$1.9B | -$1.9B | $44M |
| Accumulated OCI | $63M | $69M | $75M | $74M | $0 |
| Total Stockholders Equity | $681M | $667M | $707M | $759M | $802M |
| Total Liabilities & Equity | $982M | $1.0B | $1.1B | $1.1B | $1.1B |
| — Key Metrics — | |||||
| Total Debt | $6M | $2M | $1M | $4M | $2M |
| Net Debt | -$81M | -$133M | -$200M | -$272M | -$296M |
| Total Investments | $313M | $305M | $64M | $64M | $300M |